Clinical Analysis of the Efficacy of Intensive Immunosuppressive Therapy in 68 Children With Severe Aplastic Anemia

doi:10.3877/cma.j.issn.1673-5250.2009.04.102

Objective

To analyze the therapeutic efficacy of intensive immunosuppressive therapy(IST) in children with severe aplastic anemia(SAA) and compared it with only cyclosporine A(CSA) therapy, and evaluate the relation between granulocyte colony stimulating factor (G-CSF) reaction and therapeutic efficacy before intensive immunosuppressive therapy.

Methods

The study cohort consisted of 68 consecutive patients diagnosed as severe aplastic anemia in the Department of Pediatrics, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University between January 2000 and November 2007. Fifty-five cases of 68 patients accepted intensive immunosuppressive group (IST group), while other 13 cases received only cyclosporine A (CSA group) because of poor economy. The different therapeutic efficacy of these two regimens was analyzed. The procedure of this study was consistent with ethical standard established by the committee of investigation in human beings of Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, and it was approved by this committee. Informed consent was obtained from all participates.24 cases of severe aplastic anemia received granulocyte colony stimulating factor as experimental treatment before intensive immunosuppressive therapy according to the degree of peripheral blood count's response to granulocyte colony stimulating factor. These 24 cases were divided into reaction sub-IST group (n=13)and non-reaction sub-IST group.(n=11). The differences of therapeutic efficacy at the end of 6 months after treatment and long-term effects were observed.

Results

The average effective time of IST group and CSA group after treatment were 3.4 months(1~13 months) and 4.5 months (1~15 months), respectively. The efficacy rates of IST group and CSA group at the end of 1st, 3rd, 6th, 9th and 12th months after treatment were 70.9%, 58.2%, 79.5%, 87.2% and 89.7% vs. 46.2%, 38.5%, 46.2%, 61.5% and 61.5%, respectively. More than 1 year follow-up of 39 patients in IST group, the total efficacy rate was 89.7%(35/39). More than 1 year follow-up of 13 patients in CSA group, the total efficacy rate was 61.5%(8/13). There had statistically significant difference between two groups(χ²=5.419, P<0.05). The efficacy rates of reaction sub-IST group and non-reaction sub-IST group to granulocyte colony stimulating factor at the end of 6th months after treatment were 76.9% and 45.6%, respectively.There had no significant difference between two groups (P>0.05). The total efficacy rates of reaction sub-IST group and non-reaction sub-IST group to granulocyte colony stimulating factor were 92.3%, (12/13)and 54.5%(6/11), respectively.The former was significant higher than that of the latter. There was statistically significant difference in these two groups(P<0.05). The efficacy of intensive immunosuppressive therapy was better than that of single-use cyclosporine A. The average effective time of IST group and CSA group after treatment were 3.4 months and 4.5 months, respectively. The efficacy of IST group and CSA group at 1 year after treatment were 89.7% and 61.5%, respectively. The total efficacy rate of reaction sub-IST group and non-reaction sub-IST group to granulocyte colony stimulating factor were 92.3% and 54.5%, respectively.

Conclusion

The therapeutic efficacy of intensive immunosuppressive therapy in children with severe aplastic anemia is better than that of cyclosporine A therapy only. Children with severe aplastic anemia who responded well to granulocyte colony stimulating factor had a better prognosis in the intensive immunosuppressive therapy.

Key words: severe aplastic anemia(SAA), immunosuppressive therapy(IST), granulocyte colony stimulating factor(G-CSF), child

	1 Bacigalupo A, Hows J, Gordon–Smith EC, et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: A report of the BMT Working Party. Bone Marrow Transplant，1988，3(6)：531–535.
	2　Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: A prospective study of the effect of early marrow transplantion on acute mortality.Blood，1976，48(1)：63–70.
	3　Chen C, Fang JP, Huang SL，et al.The clinical analysis of the efficacy of immunosuppressive therapy in 54 children patients with severe aplastic anemia. Chin J Pediatr.2006，44(11)：841–844.
	4　Stary J，Locatelli F，Niemeyer CM，et al.Stem cell transplantation for aplastic anemia and myelodysplastic syndrome.Bone Marrow Transplant, 2005，35(suppl 1)：S13–S16.
	5　Further M，Rampf U，Baumann I，et al.Immunosuppressive therapy for aplasic anemia in children：A more severe disease predicts better survival.Blood，2005，106(6)：2102–2104.
	6　Jeng MR，Naidu PE，Rieman MD，et al.Granulocyte–macrophage colony stimulating factor and immunosuppression in the treatment of pediatric aquired severe aplastic anemia. Pediatr Blood Cancer, 2005, 45(2): 170–175.
	7　Killick SB，Marsh JC，Gordon–Smith EC，et al.Long–term outcome of aquired aplastic anemia in children：Comparison between immunosuppressive therapy and bone marrow transplantation.Br J Haematol, 2000, 111: 321–328.
	8　Goldenberg NA，Graham DK，Liang X，et al.Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A．Pediatr Blood Cancer, 2004，43(7)：718–722.
	9　Kojima S，Hibi S，Kosaka Y，et al.Immunosuppressive therapy using antithymocyte globulin，cyclosporine, and danazol with or without human granulocyte colony–stimulating factor in children with acquired apastic anemia.Blood，2000，96(6)：2049–2054.
	10　Scheinberg P, Wu CO, Nunez O, et al.Long–term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.J Pediatr，2008，153(6)：814–819.
	11　Lu J，Chai YH, Cao YF，et al. The clinical prophase observation of the therapeutic effect of antilymphocyte globulin combining cyclosporin A in treatment of pediatric severe aplastic anemia.China Pediatr Blood，2005, 10(3)：103–105.
	12　Futher M，Burdach S，Ebell W，et al.Relapse and clonal disease in chidren with aplastic anemia after immunosuppressive therapy(IST)：The SAA 94 experience.German/Austrian Pediatric Aplastic Anemia Working Group. Klin Pediatr，1998，210(4)：173–179.
	13　De–Medeiros CR，Ribeiro RC，Bittencourt MA.Long–term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin.Braz J Med Biol Res，2000，33(5)：553–558.
	14　Socie G, Mary JY, Schrezenmeier H, et al. Granulocyte–stimulating factor and severe aplastic anemia: A survey by the European Group for Blood and Marrow Transplantation (EBMT)．Blood，2007 109(7): 2794–2796.
	15　Shichino H，Mugishima H，Takamura M，et al.Treatment of aplastic anemia with antithymocyte globulin，cyclosporin A，methylprednisolone, danazol and recombinant human grannlocyte–colony stimulating factor. Acta Paediatr Jpn，1996，38(6)：644–647.
	16　Huang YL, Huang SL.Progress of immune–mediated pathogenesis and treatment in children patients with aplastic anemia. Chin J Pediatr，2006，44(2)：153–155.
	17　Yong NS, Maciejewski JP. Aplastic anemia. In: Ronald H. Hematology–basic principles and practice.3rd ed.Beijing ：Harcourt Asia Churchill Livingstone，2001，297–331.
	18　Mourad G, Garrigue V, Squifflet JP, et al. Induction versus moninduction in renal transplant recipients with tacrolimus–based immunosuppression. Transplantation，2001，72(6)：1050–1055.

[1]	Xuan Zhang, Yutong Ma, Yuqian Miao, Yun Zhang, Shiwen Wu, Xiaochu Dang, Yingying Chen, Zhaoming Zhong, Xuejuan Wang, Miao Hu, Yanfeng Sun, Xiuzhu Ma, Faqin Lyu, Haiyan Kou. Ultrasound assessment of diaphragm function in pediatric patients with Duchenne muscular dystrophy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1068-1073.
[2]	Baofu Zhang, Jin Yu, Jingjing Ye, Jiangen Yu, Xiaohui Ma, Xiwang Liu. Echocardioimagedata diagnosis of anomalous pulmonary venous connection caused by congenital malposition of the septum primum[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1074-1080.
[3]	Dan Han, Ting Wang, Huan Xiao, Lirong Zhu, Jingyu Chen, Yi Tang. Diagnostic value of contrast enhanced ultrasound versus contrast enhanced computed tomography in benign and malignant liver lesions in children[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 939-944.
[4]	Tingting Liu, Yanbing Lin, Shan Wang, Murong Chen, Zijian Tang, Dongling Dai, Bei Xia. Evaluation of metabolic dysfunction-associated fatty liver disease in children by ultrasound-guided attenuation parameter[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 787-794.
[5]	Yuhan Zhou, Huan Xiao, Chunjiang Yang, Juan Zhou, Lirong Zhu, Juan Xu, Fangting Mou. Diagnostic value of ultrasound in children with temporary hip synovitis[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 795-800.
[6]	Jiu Wang, Jun Chen, Xia Zhu, Yangjin Mima, Sheng Zhao, Xinlin Chen, Jianhua Li, Shuang Wang. Effect of implementing fetal systemic ultrasound screening in Material and Child Health Hospital of Shannan[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 728-733.
[7]	Jie Mi, Chen Chen, Jialing Li, Haina Pei, Hengbo Zhang, Fei Li, Dongjie Li. Analysis of the characteristics of children's head and face trauma[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(06): 511-515.
[8]	Tao Ma, Chunwei Ye, Tao Liu, Wenxi Peng, Zhipeng Li. Comparison of laparoscopic and open disconnected pyeloplasty in the treatment of ureteropelvic junction obstruction in children[J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 605-610.
[9]	Lei Wang, Shaohua Wang, Haizhen Niu, Tengfei Yin. Application of early warning intervention based on risk assessment in perioperative nursing of children with inguinal hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 768-772.
[10]	Fang Li, Rui Xu, Yangyang Li, Xiuquan Shi. Application of the concept of evidence-based medicine in children with inguinal hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 782-786.
[11]	Lei Lyu, Xiao Feng, Kaiming He, Kaining Zeng, Qing Yang, Haijin Lyu, Huimin Yi, Shuhong Yi, Yang Yang, Binsheng Fu. Value of revised King's score in evaluation of live transplantation timing for children with acute liver failure due to Wilson's disease and literature review[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 661-668.
[12]	Zehui Huang, Jiexian Liang, Wei Zeng. Application of dexmedetomidine combined with esketamine in painless gastroscopy in children[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 510-513.
[13]	Xiangyu Zhu, Jianmei Wang, Hui Zhang, Hongying Ye. Correlation analysis between left ventricular function parameters and liver cirrhosis using non-invasive left ventricular pressure-strain cycle[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 494-498.
[14]	Shaohong Zhuo, Xiuling Lin, Cuimei Zhou, Weilian Xiong, Xingzao Ma. Application value of CD64 index combined with serum SAA/CRP and PCT in the diagnosis of children with infectious gastrointestinal diseases[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 505-509.
[15]	Jing Li, Lingling Zhang, Wei Xing. Value of concept of interest induction before anesthesia induction in pediatric surgery and its effect on family satisfaction[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 812-817.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export